Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Supreme Court Abortion Case Impacting Access To Medication

Supreme Court case on mifepristone access in abortion with potential nationwide healthcare implications.

Top News

Robe & Gavel: SCOTUS concludes March 2024 sitting

Welcome to the March 25 edition of Robe & Gavel, Ballotpedia’s newsletter about the Supreme Court of the United States (SCOTUS) and other judicial happenings around the U.S.

Ballotpedia

What's at stake in the Supreme Court mifepristone case

The case could affect not just abortion access but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Supreme Court To Revisit Abortion Debate Amid Medication Access Dispute

The upcoming Supreme Court case on mifepristone access in abortion procedures sparks contentious debates that strike at the heart of the controversial issue.

International Business Times

US Supreme Court Abortion Pill Battle Over Science Claims

The US Supreme Court is in a contentious debate over FDA regulations on the abortion pill, with conflicting scientific claims. This case has broader implic...

Top News

How the abortion pill case at the supreme court could undo the FDA

The mifepristone case is viewed with trepidation by the medical industry and could have enormous consequences for drug regulation

The Guardian - US

‘Cruel’: the supreme court could send one-time abortion deserts like Hawaii back in time

States in which abortion is legal but was long inaccessible have benefited from the FDA’s expansion of a key abortion drugExplainer: the mifepristone case

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Crisis if SCOTUS restricts mifepristone

The safety of abortion drugs is well-established, but an upcoming SCOTUS ruling could unravel decades of precedent

Salon

Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

The benefits of drugs such as donanemab, aducanumab and lecanemab are proving harder to quantify than potential harms, experts say

The Guardian - AU

AI Chatbots: Emerging Mental Health Tools Or Self-Help Apps?

Explore the emergence of mental health chatbots, their benefits, concerns, and potential impact on mental health care.

Top News

How rightwing groups used junk science to get an abortion case before the US supreme court

Anti-abortion researchers ‘exaggerate’ and ‘obfuscate’ in their scientific papers – but by the time they’re published, it’s too late

The Guardian - US

Solicitor General Takes Vaping to the Supreme Court

The Department of Justice is asking the Supreme Court to review the Fifth Circuit's Rejection of the FDA's "Surprise Switcheroo."

Reason

Withings Body Scan: A smart scale system that lets you measure and analyze all the things!

Withings calls their Body Scan smart scale a "connected health station." With its premium build and price, it is exactly that and worth every penny, if you have it to spend.

iMore

US Appeals Court Upholds FDA's Cigarette Warning Labels

US appeals court upholds FDA's graphic warning labels on cigarette packaging, supporting public health efforts and raising awareness about smoking dangers.

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

2024's "Dirty Dozen" list revealed

Strawberries, leafy greens, grapes and green beans are just a few items on the EWG's annual list

WEKU

Medicare plans can now cover Wegovy for patients at risk of heart disease

This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.

Roll Call

Supreme Court to hear oral arguments on medication abortion drug - Roll Call

The Supreme Court hears arguments Tuesday in a challenge that could limit access to a widely used drug for medication abortions.

Reason

After Nearly 20 Years, They Finally Freed the Frozen Cherry Pie

The market offers many alternatives to bad desserts. We don’t need the FDA to step in.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharma Gems Poised for Breakthroughs

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

Reason

'15 Days To Slow the Spread': On the Fourth Anniversary, a Reminder to Never Give Politicians That Power Again

In the name of safety, politicians did many things that diminished our lives—without making us safer.

The Hindu

The way we name cancers could affect access to treatment, researchers say

Revamping cancer classification to focus on molecular characteristics over organ of origin can result in more effective and timely treatment, a group of doctors has said.

Top News

Lawsuits Against Gilead Sciences Could Stifle Medical Innovation

Lawsuit against Gilead Sciences raises concerns about innovation impact in drug development and potential implications on future product development.

The Hindu

Many pharma companies that bought electoral bonds faced regulatory actions

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

WEKU

Despite bans in some states, more than a million abortions were provided in 2023

That's the highest number in more than a decade, according to new research. Medication abortion made up a larger share of the total than in 2020.

StockNews.com

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

1 … 126 127 128 129

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

222 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.